
Name: | (R)-(3-methyl-1-(pyrazine-2-carboxamido)butyl)boronic acid |
Catalogue No. | VL1200004 |
CAS No. | N/A |
Molecular Formula | C10H16BN3O3 |
Molecular Weight | 237.07 g/mol |
Status | In-stock |
IUPAC Name | (R)-(3-methyl-1-(pyrazine-2-carboxamido)butyl)boronic acid |
Synonyms | Bortezomib Impurity 7 |
Description | Bortezomib Impurity E or (R)-(3-methyl-1-(pyrazine-2-carboxamido)butyl)boronic acid is associated impurity of Bortezomib. Bortezomib is employed to treat two forms of blood cancer in adults, multiple myeloma and mantle cell lymphoma (MCL). |
References | “Sci-Hub | Review of Bortezomib Treatment of Antibody-Mediated Rejection in Renal Transplantation | 10.1089/Ars.2014.5892.” Hkvisa.net, 2014, sci-hub.hkvisa.net/10.1089/ars.2014.5892. |